Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coron...

por Gu, Youlan L, Fokkema, Marieke L, Kampinga, Marthe A, de Smet, Bart JGL, Tan, Eng S, van den Heuvel, Ad FM, Zijlstra, Felix
Publicado 2009